Imx Ca 125
510(k) K964185
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK964185 | Date4 Nov 1997 | StatusActive |
Recalls
-
- Terminated Z-0322-04
- Terminated Z-0320-04
- Terminated Z-0318-04
- Terminated Z-0319-04
The CA 125 assay product inserts list the incorrect storage instructions for the CA 125 Calibrators and Controls, and the product information letter (PI-P) shipped with the products to correct the storage conditions, 69-6349/R2, refers to an outdated control package insert, 39-1642/R3, instead of the current control package insert 34-1047/R4
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LTK
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.6010
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 24 Sep 2026
The Imx Ca 125 is an epithelial ovarian tumor-associated antigen test. It is designed for use in clinical laboratory settings to detect the presence of the CA 125 antigen.
This device is classified as a Class 2 medical device under regulation number 866.6010. It has received FDA 510(k) clearance under the submission number K964185.